PH Deck logoPH Deck

Fill arrow
Genome-OS: Strategic R&D Console
Brown line arrowSee more Products
Genome-OS: Strategic R&D Console
🧬 Your R&D Copilot — From Genes to Regulatory Failures
# Research Tool
Featured on : Oct 1. 2025
Featured on : Oct 1. 2025
What is Genome-OS: Strategic R&D Console?
A strategic R&D console built for biotech teams — turning 7.9M+ genes, diseases, trials, failures & regulatory records into actionable strategies, instantly.
Problem
Biotech teams manually research genes, diseases, trials, and regulatory records, which is time-consuming and inefficient due to fragmented data sources.
Solution
Strategic R&D console enabling biotech teams to analyze 7.9M+ genes, diseases, trials, failures, and regulatory records instantly for actionable insights via AI-driven data aggregation.
Customers
Biotech researchers, R&D managers, and regulatory affairs specialists in pharmaceutical or biotech companies seeking data-driven R&D decisions.
Unique Features
Centralized access to 7.9M+ scientific records, real-time regulatory failure analysis, and AI-powered strategy generation.
User Comments
Accelerates drug discovery timelines
Solves data fragmentation in R&D
Critical for regulatory risk mitigation
User-friendly interface for complex queries
Reduces reliance on external consultants
Traction
Newly launched on Product Hunt (exact metrics unspecified)
Positioned as a niche solution leveraging 7.9M+ curated biomedical data points
Market Size
Global biotechnology market projected to reach $1.55 trillion by 2030 (Grand View Research, 2023), driving demand for R&D efficiency tools.